Alzamend Neuro, Inc.
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial, wh…
Biotechnology
US, Atlanta [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Alzamend Neuro, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDAlzamend Neuro, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Alzamend Neuro, Inc..
If you want to see a demo, head over to the financial segments of AAPL